Latest News about Biotech
Recent news which mentions Biotech
CRISPR Therapeutics' Gene-Edited Oncology Pipeline To Focus On Expanded Use In Autoimmune Diseases
December 05, 2023
Tickers
CRSP
From Benzinga
Longeveron (NASDAQ: LGVN) Announces Positive Top-Line Results For Its Phase 2a Clinical Trial For The Treatment Of Mild Alzheimer's Disease with Lomecel-B™
December 05, 2023
Tickers
LGVN
From Benzinga
Longeveron (NASDAQ: LGVN) Announces Positive Top-Line Results For Its Phase 2a Clinical Trial For The Treatment Of Mild Alzheimer's Disease with Lomecel-B™
December 05, 2023
Tickers
LGVN
From Benzinga
Roche's Combination Therapy Shows Improved Progression Free Survival In Certain Breast Cancer With Mutation
December 05, 2023
From Benzinga
Investor Demand for Clarity Grows Amid Sanofi's Strategic R&D Shift
December 05, 2023
Tickers
SNY
From Benzinga
EyePoint (EYPT) stock price went parabolic: brace for a pullback
December 05, 2023
Tickers
EYPT
From Invezz
EXCLUSIVE: Ocean Biomedical Announces Publication of Breast Cancer Research On New Tumor Suppression Pathway for Proprietary Antibody
December 05, 2023
Tickers
OCEA
From Benzinga
Undervalued VistaGen Therapeutics, Analyst Highlights Potential In Anxiety Treatment
December 04, 2023
Tickers
VTGN
From Benzinga
Why Newly Listed Korro Bio Shares Are Gaining Today
December 04, 2023
From Benzinga
QuBind.com Makes Major Strides in T-Cell Immunotherapy with Revolutionary AI Innovation
December 04, 2023
From PRLog
Why Is Cancer Focused CEL-SCI Stock Trading Higher Today?
December 04, 2023
Tickers
CVM
From Benzinga
89bio Outlines Roadmap For Pivotal Studies For Lead Program In Fatty Liver Disease
December 04, 2023
Tickers
ETNB
From Benzinga
Valneva Says Single Chikungunya Vaccine Shows Long-Lasting Antibody Response In Younger, Older Adults
December 04, 2023
Tickers
VALN
From Benzinga
Why Is Neurodegenerative Disease-Focused Alterity Therapeutics Stock Trading Over 200% Higher Today?
December 04, 2023
Tickers
ATHE
From Benzinga
Why Is Age-Related Blindness Focused EyePoint Pharmaceuticals Stock Trading Over 300% Today?
December 04, 2023
Tickers
EYPT
From Benzinga
Top Contenders Emerge in Johnson & Johnson's Race for New CEO, Plans Under Spotlight After Unexpected Departure
December 04, 2023
Tickers
JNJ
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.